Retinal Ischemia: Therapeutic Effects and Mechanisms of Paeoniflorin
Open Access
- 11 November 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 10924
Abstract
Retinal ischemia is a key factor in the progression of vision-threatening ocular diseases, including central retinal artery/vein occlusion, exudative age-related macular degeneration (eAMD), and proliferative diabetic retinopathy. This study investigates the effects of paeoniflorin along with its related neuroprotective molecular pathways in the treatment of retinal ischemia. Free radical or ischemic-like damage was induced by incubating retinal pigment epithelium (RPE) cells for 24 h with 1 mM hydrogen peroxide (H2O2) or by subjecting retinal neuronal cells to 8 h of oxygen–glucose deprivation (OGD). Both treatments caused significant cell loss. Treatment with paeoniflorin significantly increased cell viability at 0.5 mM in both cell types. In a Wistar rat model of retinal ischemia and reperfusion (I/R) elicited by sustained high intraocular pressure (HIOP), pre-treatment with 0.5 mM paeoniflorin mitigated the ischemia-induced decline in ERG b-wave amplitude, reduction in whole and inner retinal thickness, loss of fluorogold-labeled retinal ganglion cells, and formation of apoptotic cells. Meanwhile, paeoniflorin effectively downregulated pro-neovascular mediators β-catenin, hypoxia-inducible factor 1-alpha (HIF-1α), vascular endothelial growth factor (VEGF), and the pro-inflammatory/angiogenic biomarker angiopoietin-2 (Ang-2), producing effects similar to the Wnt/β-catenin inhibitor (dickkopf-related protein 1), anti-angiogenic pigment epithelium-derived factor (PEDF), and anti-VEGF Avastin (bevacizumab). These findings suggest that paeoniflorin may protect against retinal ischemia through its anti-inflammatory, anti-neovascular/angiogenic, antioxidative, and neuroprotective properties.Keywords
This publication has 50 references indexed in Scilit:
- Paeoniflorin alleviated STZ-induced diabetic retinopathy via regulation of the PDI/ADAM17/MerTK pathwayInternational Immunopharmacology, 2025
- Antioxidant effects of Paeoniflorin and relevant molecular mechanisms as related to a variety of diseases: A reviewBiomedicine & Pharmacotherapy, 2024
- The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunitiesGenes & Diseases, 2024
- Paeoniflorin inhibits colorectal cancer cell stemness through the miR‐3194‐5p/catenin beta‐interacting protein 1 axisThe Kaohsiung Journal of Medical Sciences, 2023
- Preparation of paeoniflorin from the stems and leaves of Paeonia lactiflora Pall. ‘Zhongjiang’ through green efficient microwave-assisted extraction and subcritical water extractionIndustrial Crops and Products, 2021
- A detailed three-step protocol for live imaging of intracellular traffic in polarized primary porcine RPE monolayersExperimental Eye Research, 2014
- Retinal pigment epithelium development, plasticity, and tissue homeostasisExperimental Eye Research, 2014
- Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edemaGraefe's Archive for Clinical and Experimental Ophthalmology, 2010
- Double Antiangiogenic Protein, DAAP, Targeting VEGF-A and Angiopoietins in Tumor Angiogenesis, Metastasis, and Vascular LeakageCancer Cell, 2010
- Angiopoietin‐2 enhances retinal vessel sensitivity to vascular endothelial growth factorJournal of Cellular Physiology, 2004